DarioHealth Corp reports results for the quarter ended in September - Earnings Summary

DarioHealth

15/11/2022 01:45

* DarioHealth Corp  DRIO.OQ  reported a quarterly adjusted
loss
of 64 cents​​ per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of 76 cents per share.
    * Revenue rose 17.3% to $6.61 million from a year ago;
analysts
expected $6.23 million. 
    * DarioHealth Corp's reported EPS for the quarter was a loss
of 70
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * DarioHealth Corp shares had fallen by 11.9% this
quarter and
lost 68.5% so far this year.
    * The company reported a quarterly loss of $16.13 million.
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 01:45 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.76          -0.64          Beat
 Jun. 30 2022      -0.71          -0.74          Missed
 Mar. 31 2022      -0.96          -0.74          Beat
 Dec. 31 2021      -1.06          -1.09          Missed